| abstract |
The present invention provides methods and compositions for modification and regulationnof glucose and lipid metabolism, generally to reduce insulin resistance, hyperglycemia,nhyperinsulinemia, obesity, hyperlipidemia, hyperlipoprotein-emia (such as chylomicrons,nVLDL and LDL), and to regulate body fat and more generally lipid stores, and, morengenerally, for the improvement of metabolism disorders, especially those associated withndiabetes, obesity and/or atherosclerosis. |